Phase 2 neurogenic detrusor overactivity Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization
neurogenic detrusor overactivitySpinal Cord Injuries
EG 42716 enrolled4 locationsNCT06596291
Recruiting
Phase 2Phase 3
A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC
neurogenic detrusor overactivity
Urovant Sciences GmbH85 enrolled6 locationsNCT05491525